Skip to main content
SpringerLink
Log in

What if multiple sclerosis isn't an immunological or a viral disease? the case for a circulating toxin

  • Overview
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

The literature contains studies on many causes of demyelination: Vascular occlusion —exogenous toxins—allergic reactions—and virus diseases. There remains, however, a small group of conditions which seems to have been ignored almost completely in discussions of cerebral demyelination. These consist of brain damage apparently resulting from some toxin liberated within the human body and not obtained from the outside.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Baker, A. B. 1950. Demyelination resulting from endogenous toxins. Assoc. Res. Nerv. Ment. Dis. 28:59–74.

    Google Scholar 

  2. Dawson, J. W. 1916. The histology of disseminated sclerosis. Edinburgh Med. J. 17:377–410.

    Google Scholar 

  3. Hassin, G. B. 1922. Studies in the pathogenesis of multiple sclerosis. Arch. Neurol. Psychiatr. 7:589–607.

    Google Scholar 

  4. Globus, J. H., andStrauss, I. 1928. Progressive degenerative subcortical encephalopathy. Arch. Neurol. Psychiatr. 20:1190–1228.

    Google Scholar 

  5. Meyer, A., andTennent, T. 1936. Familial Schilder's disease. Brain 59:100–112.

    Google Scholar 

  6. Peters, G. 1968. Multiple sclerosis. Pages 821–843,in Minckler, J. (ed.), Pathology of the Nervous System, Vol. 1, McGraw-Hill, New York.

    Google Scholar 

  7. Lumsden, C. E. 1970. The neuropathology of multiple sclerosis. Pages 217–309,in Vinken, P., and Bruyn, G. W. (eds.), Handbook of Clinical Neurology, Vol. 9, North Holland Publ., Amsterdam.

    Google Scholar 

  8. Brownell, B., andHughes, J. T. 1962. The distribution of plaques in the cerebrum in multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 25:315–320.

    Google Scholar 

  9. Hopf, H. C. 1965. Leitgeschwindigkeit motorischer nerven bei der multiplen sklerose und unter dem einfluss hoher cortisonmedikation. Dtsch. Z. Nervenheilkd. 187:522–526.

    Google Scholar 

  10. Hassin, G. B. 1921. Pathological studies in the pathogenesis of multiple sclerosis. Assoc. Res. Nerv. Ment. Dis. 2:144–156.

    Google Scholar 

  11. Hasson, J., Terry, R. D., andZimmerman, H. M. 1958. Peripheral neuropathology in multiple sclerosis. Neurology 8:503–510.

    Google Scholar 

  12. Margulis, M. S. 1933. Uber die pathologische anatomie und pathogenese der multiplen sklerose. Dtsch. Z. Nervenheilkd. 131:125–143.

    Google Scholar 

  13. Schob, F. 1907. Ein beitrag zur pathologischen anatomie der multiplen skelerose. Monatsschr. Psychiatr. Neurol. 22:62–87.

    Google Scholar 

  14. Strahuber, A. 1903. Ueber degenerations-und proliferations vorgange bei multipler sklerose des nervensystems, nebst bemerkungen zur aetiologie und pathogenese der erkrankung. Beitr. Pathol. Anat. 33:409–480.

    Google Scholar 

  15. Pollock, M., Calder, C., andAllpress, S. 1977. Peripheral nerve abnormality in multiple sclerosis. Ann. Neurol. 2:41–48.

    Google Scholar 

  16. Andrews, J. M. 1972. The ultrastructural neuropathology of multiple sclerosis. Pages 23–49,in Wolfgram, F., Ellison, G. W., Stevens, J. G., and Andrews, J. M. (eds.), Multiple Sclerosis: Immunology, Virology and Ultrastructure. UCLA Forum in Medical Sciences No. 16, Academic Press, New York.

    Google Scholar 

  17. Lampert, P. W. 1965. Demyelination and remyelination in experimental allergic encephalomyelitis. J. Neuropathol. Exp. Neurol. 24:371–385.

    Google Scholar 

  18. Meyer, A. 1928. Experimentalle erfahrungen uber die kohlenoxydvergiftung des zentralnervensystems. Ztschr. Ges. Neurol. Psychiatr. 112:187–212.

    Google Scholar 

  19. Putnam, T. J., McKenna, J., andMorrison, L. R. 1931. Studies in multiple sclerosis. 1. The histogenesis of experimental sclerotic plaques and their relation to multiple sclerosis. JAMA 97:1591–1596.

    Google Scholar 

  20. Yant, W. P., Chornyak, J., Schrenck, H. H. Patty, F. A., andSayers, R. R. 1934. Studies in asphyxia. U.S. Treasury Dept., Public Health Bull. 211.

  21. Ferraro, A. 1933. Experimental toxic encephalomyelopathy. Psychiatr. Q. 7:267–283.

    Google Scholar 

  22. Hurst, E. W. 1940. Experimental demyelination of the central nervous system. 1. The encephalopathy produced by potassium cyanide. Aust. J. Exp. Biol. Med. Sci. 18:201–223.

    Google Scholar 

  23. Hurst, E. W. 1942. Experimental demyelination of the central nervous system. 3. Poisoning with potassium cyanide, sodium azide, hydroxylamine, narcotics, carbon monoxide, etc. with some consideration of bilateral necrosis occurring in the basal nuclei. Aust. J. Exp. Biol. Med. Sci. 20:297–312.

    Google Scholar 

  24. Hurst, E. W. 1944. A review of some recent observations on demyelination. Brain 67:103–124.

    Google Scholar 

  25. Putnam, J. J. 1883. Lead poisoning simulating other diseases. J. Nerv. Ment. Dis. 10:466–469.

    Google Scholar 

  26. Verhaart, W. J. C. 1941. Lead encephalopathy simulating diffuse sclerosis in a Chinese infant. Am. J. Dis. Child. 61:1246–1250.

    Google Scholar 

  27. Sauer, R. M., Zook, B. C., andGarner, F. M. 1970. Demyelinating encephalomyelopathy associated with lead poisoning in nonhuman primates. Science 169:1091–1093.

    Google Scholar 

  28. Smith, M. E. 1973. Studies on the mechanism of demyelination: Triethyl tin-induced demyelination. J. Neurochem. 21:357–372.

    Google Scholar 

  29. Baker, A. B., andTichy, F. Y. 1953. The effect of the organic solvents and industrial poisonings on the central nervous system. Assoc. Res. Nerv. Ment. Dis. 32:475–505.

    Google Scholar 

  30. Korenke, H. D., andPribilla, O. 1969. Suicid durch einmalige inhalation von tetrachlorkohlenstoff (CCl4) mit leukoencephalopathie. Arch. Toxikol. 25:109–126.

    Google Scholar 

  31. Weil, A. 1930. The effect of hemolytic toxins on nervous tissue. Arch. Pathol. 9:828–842.

    Google Scholar 

  32. Gonsette, R., Andre-Balisaux, G., andDelmotte, P. 1966. Permeability of the cerebral vessels. VI. Experimental demyelination provoked by substances acting on the blood-brain barrier. Acta Neurol. Belg. 66:247–262.

    Google Scholar 

  33. Davis, L., Haven, H., Givens, J. H., andEmmett, J. 1931. Effects of spinal anesthetics on the spinal cord and its membranes. JAMA 97:1781–1785.

    Google Scholar 

  34. Friedman, E. D. 1953. Neurologic sequelae of spinal anesthesia. N. Y. State J. Med. 53:1864–1866.

    Google Scholar 

  35. Poser, C. M. 1973. Demyelination in the central nervous system in chronic alcoholism: Central pontine myelinolysis and Marchiafava-Bignami's disease. Ann. N.Y. Acad. Sci. 215:373–381.

    Google Scholar 

  36. Marchiafava, E., andBignami, A. 1903. Sopra un'alterazione del corpo calloso osservata in soggetti alcoclisti. Riv. Patol. Nerv. Ment. 8:544–549.

    Google Scholar 

  37. Ironside, R., Bosanquet, F. D., andMcMenemey, W. H. 1961. Central demyelination of the corpus collosum (Marchiafava-Bignami disease). Brain 84:212–230.

    Google Scholar 

  38. Lynch, M. J. G. 1960. Brain lesions in chronic alcoholism. Arch. Pathol. 69:342–353.

    Google Scholar 

  39. Adams, R. D., Victor, M., andMancall, E. L. 1959. Central pontine myelinolysis. Arch Neurol. Psychiatr. 81:154–172.

    Google Scholar 

  40. Klavins, J. V. 1963. Central pontine myelinolysis. J. Neuropathol. Exp. Neurol. 22:302–317.

    Google Scholar 

  41. Sherins, R. J., andVerity, M. A. 1968. Central pontine myelinolysis associated with acute haemorrhagic pancreatitis. J. Neurol. Neurosurg. Psychiatr. 31:583–588.

    Google Scholar 

  42. Chason, J. L., Landers, J. W., andGonzalez, J. E. 1964. Central myelinolysis. J. Neurol. Neurosurg. Psychiatr. 27:317–325.

    Google Scholar 

  43. Waechter, R. V., andHoldorff, B. 1973. Akute zentrale pontine myelinolyse mit multifokaler ausbreitung. Z. Neurol. 204:193–208.

    Google Scholar 

  44. Balo, J. 1928. Encephalitis periaxialis concentrica. Arch. Neurol. Psychiatr. 19:242–264.

    Google Scholar 

  45. Hallervorden, J., andSpatz, H. 1933. Uber die konzentrische sklerose und die physikalischchemischen faktoren bei der ausbreitung von entmarkungsprozessen. Arch. Psychiatr. 98:641–701.

    Google Scholar 

  46. Davison, C., andKeschner, M. 1933. Myelitic and myelopathic lesions (A clinicopathologic study). Arch. Neurol. Psychiatr. 29:600–614.

    Google Scholar 

  47. Alvord, E. C., Stevenson, L. D., Vogel, F. S., andEngle, R. L. 1950. Neuropathological findings in phenylpyruvic oligophrenia (phenylketonuia). J. Neuropath. Exp. Neurol. 9:298–310.

    Google Scholar 

  48. Forssman, H., Kristensson, K., Sourander, P., andSvennerholm, L. 1967. Histological and chemical studies of a case of phenylketonuria with long survival. J. Ment. Def. Res. 11:194–206.

    Google Scholar 

  49. Malamud, N. 1966. Neuropathology of phenylketonuria. J. Neuropathol. Exp. Neurol. 25:254–268.

    Google Scholar 

  50. Gatfield, P. D., Taller, E., Hinton, G. G., Wallace, A. C., Abdelnour, G. M., andHaust, M. D. 1968. Hyperpipecolatemia: A new metabolic disorder associated with neuropathy and hepatomegaly: A case study. Can. Med. Assoc. J. 99:1215–1233.

    Google Scholar 

  51. Globus, J. H., andBender, M. B. 1936. Disseminated toxic degenerative encephalopathy (disseminated sclerosing demyelination) secondary to extensive and severe burns. J. Nerv. Ment. Dis. 83:518–529.

    Google Scholar 

  52. Solcher, H. 1971. Striare initiale entmarkungsherde nach verbrennung mit langerer uberlebungszeit. Acta Neuropathol. (Berlin) 19:75–78.

    Google Scholar 

  53. Knutson, J., andBaker, A. B. 1945. The central nervous system in uremia. Arch. Neurol. Psychiatr. 54:130–140.

    Google Scholar 

  54. Tichy, F. Y. 1950. Uremia encephalitis. J. Neuropathol. Exp. Neurol. 9:344–346.

    Google Scholar 

  55. Olsen, S. 1961. The brain in uremia. Acta Psychiatr. Neurol. Scand. 36(Suppl. 156):1–126.

    Google Scholar 

  56. Tyler, H. R. 1968. Neurologic disorders in renal failure. Am. J. Med. 44:734–748.

    Google Scholar 

  57. Giovannetti, S., andBarsotti, G. 1975. Uremic intoxication. Nephron 14:123–133.

    Google Scholar 

  58. Cohen, B. D. 1969. Guanidine retention and the urea cycle. Page 45,in 4th Int. Cong. Nephrology, Stockholm, June 22–27, Vol. 2, Karger, Basel.

    Google Scholar 

  59. Merrill, J. P., and Hampers, C. L. 1970. Uremia. N. Engl. J. Med. 282:953–961.

    Google Scholar 

  60. Adams, R. D., andFoley, J. M. 1953. The neurological disorder associated with liver disease. Assoc. Res. Nerv. Ment. Dis. 32:198–237.

    Google Scholar 

  61. Brown, I. A. 1957. Liver Brain Relationships, pp. 1–198, Charles C. Thomas, Springfield, Illinois.

    Google Scholar 

  62. Zieve, L., Mendelson, D. F., andGoepfert, M. 1960. Shunt encephalomyelopathy. II. Occurrence of permanent myelopathy. Ann. Intern. Med. 53:53–63.

    Google Scholar 

  63. Bechar, M., Freud, M., Kott, E., Kott, I., Kravvic H., Stern, J., Sandbank, U., andBornstein, B. 1970. Hepatic cirrhosis with post-shunt myelopathy. J. Neurol. Sci. 11:101–107.

    Google Scholar 

  64. Baltzan, M. A., Olszewski, J., andZervas, N. 1957. Chronic portohepatic encephalopathy. J. Neuropathol. Exp. Neurol. 16:410–421.

    Google Scholar 

  65. Liversedge, L. A., andRawson, M. D. 1966. Myelopathy in hepatic disease and portosystemic venous anastomosis. Lancet 1:277–279.

    Google Scholar 

  66. Marquardt, P., andWerringloer, H. W. J. 1965. Toxicity of wine. Food Cosmet. Toxicol. 3:803–810.

    Google Scholar 

  67. Balo, J., andKopassy, B. 1932. The encephalitis of dogs with Eck fistula fed on meat. Arch. Pathol. 13:80–87.

    Google Scholar 

  68. Riddell, A. G., Kopple, P. N., andMcDermott, W. V., Jr 1954. The etiology of meat intoxication in the Eck fistula dog. Surgery 36:675–684.

    Google Scholar 

  69. Alter, M., Leibowitz, U., andSpeer, J.. 1966. Risk of multiple sclerosis related to age at immigration to Israel. Arch. Neurol. 15:234–237.

    Google Scholar 

  70. Alter, M., andOkihiro, M. 1971. When is multiple sclerosis acquired? Neurology 21:1030–1036.

    Google Scholar 

  71. Ikuta, F., andZimmerman, H. M.. 1976. Distribution of plaques in 70 autopsy cases of multiple sclerosis in the United States Neurology 26 (pt. 2):26–28.

    Google Scholar 

  72. Monseu, G., andFlament-Durand, J. 1971 Pathogenesis of central pontine myelinolysis. A clinical and pathological description of three cases. Pathol. Eur. 6:75–94.

    Google Scholar 

  73. Aleu, F. P., andTerry, R. D. 1963. Central pontine myelinolysis. A report of two cases. Arch. Pathol. 76:140–146.

    Google Scholar 

  74. Burkitt, D. P. 1971. The aetiology of appendicitis. Br. J. Surg. 58:695–699.

    Google Scholar 

  75. Burkitt, D. P. 1971. Epidemiology of cancer of the colon and rectum. Cancer 28:3–13.

    Google Scholar 

  76. Putnam, T. J. 1938. The centenary of multiple sclerosis. Arch. Neurol. Psychiatr. 40:806–813.

    Google Scholar 

  77. Firth, D. 1948. The Case of Auguste D'Este. University Press, Cambridge, England.

    Google Scholar 

  78. New York Neurological Society, 1902. Multiple Sclerosis. J. Nerv. Ment. Dis. 29:288–290.

    Google Scholar 

  79. Maretschek, M., Schaltenbrand, G., andSeibert, P. 1954. Statische untersuchungen uber die multiple skelerose an hand von 947 sektionsprotokollen. Dtsch. Z. Nervenheilkd. 172:287–308.

    Google Scholar 

  80. Poskanzer, D., Walker, A. M., Yonkondy, J., andSheridan, J. L. 1976. Studies in the epidemiology of multiple sclerosis in the Orkney and Shetland Islands. Neurology 26 (pt. 2):14–17.

    Google Scholar 

  81. Leibowitz, U. 1971. Multiple sclerosis: Progress in epidemiologic and experimental research. J. Neurol. Sci. 12:307–318.

    Google Scholar 

  82. Dean, G. 1967. Annual incidence, prevalence and mortality of multiple sclerosis in white South-African born and in white immigrants to South Africa. Br. Med. J. 2:724–730.

    Google Scholar 

  83. Foster, R. M., andHarries, J. R. 1970. Multiple sclerosis in the African. Br. Med. J. 3:628.

    Google Scholar 

  84. Oh, S. J., andCalhoun, C. L. 1969. Multiple sclerosis in the Negro. J. Natl. Med. Assoc. 61:388–392.

    Google Scholar 

  85. Kurtzke, J. F., Kurland, L. T., andGoldberg, I. D. 1971. Mortality and migration in multiple sclerosis. Neurology 21:1186–1197.

    Google Scholar 

  86. Burbank, F. 1971 Patterns in cancer mortality in the United States: 1950–1967. Natl. Cancer Inst. Monag No. 33, National Institutes of Health, Bethesda, Maryland.

    Google Scholar 

  87. United States Department of Health, Education and Welfare 1963. Public Health Services. Cardiovascular Disease: 1960, Data on national and state mortality experience. Washington, D.C., Govt. Printing Office, PHS Publication No. 1083.

    Google Scholar 

  88. Strøm, A., andJensen, R.A. 1951. Mortality from circulatory disease in Norway 1940–1945. Lancet 1:126–129.

    Google Scholar 

  89. Swank, R. L. 1950. Multiple sclerosis: A correlation of its incidence with dietary fat. Am. J. Med. Sci. 220:421–430.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Reed Neurological Research Center, UCLA School of Medicine, 90024, Los Angeles, California

    Frederick Wolfgram

Authors
  1. Frederick Wolfgram
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolfgram, F. What if multiple sclerosis isn't an immunological or a viral disease? the case for a circulating toxin. Neurochem Res 4, 1–14 (1979). https://doi.org/10.1007/BF00963827

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00963827

Keywords

Search

Navigation